Arthritis, Rheumatoid: all 2,962 studies
Page 27 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.
- Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid ArthritisCompletedNCT00913432Phase 2
- TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid ArthritisStatus unknownNCT00908089Phase 4
- A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)CompletedNCT00902369Phase 2
- Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic TreatmentCompletedNCT00902005
- Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA PatientsCompletedNCT00895050
- A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid ArthritisCompletedNCT00888745Phase 1
- Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in TaiwanCompletedNCT00888576
- A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the HeartCompletedNCT00887770Phase 1
- Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)CompletedNCT00882024Phase 2
- Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in SpainCompletedNCT00881881
- AZD5672 Bioavailability Study in Healthy Male and Female SubjectsCompletedNCT00871767Phase 1
- Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid ArthritisCompletedNCT00867516Phase 2
- Vagus Nerve Stimulation in Rheumatoid ArthritisTerminatedNCT00859859Phase 1
- Assessment of Wrist Joint and Knee Joint Inflammation in Patients With Rheumatoid Arthritis by Quantitative Three Dimensional Power Doppler UltrasonographyCompletedNCT00858169
- Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha MedicationStatus unknownNCT00855322Phase 2
- Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking MethotrexateCompletedNCT00854685Phase 2
- Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University HospitalCompletedNCT00854321
- Role of Greyscale and Power Doppler Sonography in Therapy Monitoring in Early Rheumatoid Arthritis (RA)Status unknownNCT00854243
- BTT-1023 in Rheumatoid ArthritisCompletedNCT00851240Phase 1
- Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia RheumaticaCompletedNCT00847236
- Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological ChangesWithdrawnNCT00845949
- Pharmaco Kinetic Variability of Infliximab in Rheumatoid ArthritisCompletedNCT00840957
- A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.CompletedNCT00838058Phase 1
- Assessment of Body Image in Patients With Rheumatoid ArthritisCompletedNCT00832910
- Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid ArthritisCompletedNCT00831922Phase 2
- A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201TerminatedNCT00831649Phase 2
- Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar®CompletedNCT00828997Phase 4
- Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid ArthritisCompletedNCT00818064Phase 1
- Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid ArthritisCompletedNCT00815906Phase 1
- Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)CompletedNCT00815425
- Bone Resorption, Osteoclastogenesis and AdalimumabCompletedNCT00814866Not applicable
- Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid ArthritisCompletedNCT00810836Phase 2
- Marine Oils and ArthritisTerminatedNCT00805116Not applicable
- Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory ArthritisCompletedNCT00796809
- Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)CompletedNCT00794898Phase 4
- Effect of Exercise on the Disease Activity of Rheumatoid ArthritisCompletedNCT00792675Not applicable
- Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA)CompletedNCT00786227
- A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid ArthritisWithdrawnNCT00783536Phase 4
- Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal VolunteersCompletedNCT00782600Phase 1
- Computer Navigation vs Conventional Technique in Knee ArthroplastyCompletedNCT00782444Not applicable
- Ultrasonography as a Biomarker in Early Rheumatoid ArthritisCompletedNCT00781989
- A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole BloodTerminatedNCT00781469
- Spacing of TNF-blocker Injections in Rheumatoid Arthritis StudyCompletedNCT00780793Phase 4
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid ArthritisTerminatedNCT00779220Phase 2
- Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid ArthritisSuspendedNCT00777816Phase 2
- A Single Dose Study of the CAM-3001 in Patients With Rheumatoid ArthritisCompletedNCT00771420Phase 1
- BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid ArthritisCompletedNCT00771329Phase 1
- A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)CompletedNCT00771251Phase 3
- Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)CompletedNCT00764725Phase 4
- Efficacy and Safety of TAK-783 in Subjects With Rheumatoid ArthritisCompletedNCT00760968Phase 2
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid ArthritisCompletedNCT00760864Phase 2
- Curcumin in Rheumatoid ArthritisCompletedNCT00752154Early Phase 1
- Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in AustraliaCompletedNCT00751387
- Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult PatientsCompletedNCT00749645Phase 2
- The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)TerminatedNCT00748930
- Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in TaiwanStatus unknownNCT00747578
- Biologic Treatment Registry Across CanadaCompletedNCT00741793
- Long-term Clinical Effectiveness of the Delta Xtend Reverse Total ShoulderTerminatedNCT00737087Not applicable
- A Study of ARRY-371797 in Patients With Rheumatoid ArthritisCompletedNCT00729209Phase 1
- A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00727987Phase 3
- A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)WithdrawnNCT00724672
- Remicade Infusion Management ProgramCompletedNCT00723905
- Post-PMA Approval Study: 10 Year Follow-Up IDE SubjectsCompletedNCT00721994
- A Prevalence Study of Chronic Widespread Pain (CWP) Among Patients With Rheumatoid Arthritis (RA) and Control Population in Tallinn and Harjumaa CountyStatus unknownNCT00721318
- A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid ArthritisTerminatedNCT00718588Phase 1
- Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)WithdrawnNCT00717808Phase 1
- Bucillamine Study of Holding Remission After Infliximab Dose-offStatus unknownNCT00716248Phase 4
- Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid ArthritisCompletedNCT00712114Phase 1/2
- Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male VolunteersCompletedNCT00711074Phase 1
- Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056CompletedNCT00700986Phase 1
- Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?CompletedNCT00696059Phase 4
- Study to Evaluate SC Route of Administration of Ofatumumab in RA PatientsCompletedNCT00686868Phase 1
- Rosuvastatin in Rheumatoid Arthritis (RORA)CompletedNCT00679510Phase 2/3
- Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid ArthritisCompletedNCT00674635Phase 2
- Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid ArthritisCompletedNCT00667758Phase 2
- Effects of Probiotics on Rheumatoid Arthritis PatientsCompletedNCT00664820Not applicable
- Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) ParticipantsCompletedNCT00664716Phase 2
- 104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) ParticipantsTerminatedNCT00664573Phase 2
- A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)CompletedNCT00661284
- Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)CompletedNCT00660647Phase 3
- Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and PsoriasisCompletedNCT00658827
- A Study to Assess CH1504 in Patients With Active Rheumatoid ArthritisCompletedNCT00658047Phase 2
- Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis PatientsCompletedNCT00650455Phase 4
- Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody AdalimumabApproved for marketingNCT00650390
- Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid ArthritisCompletedNCT00650156Phase 1
- Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid ArthritisApproved for marketingNCT00650026
- Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid ArthritisCompletedNCT00649922Phase 4
- Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid ArthritisApproved for marketingNCT00649545
- Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With MethotrexateCompletedNCT00647920Phase 3
- A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00647491Phase 2/3
- A Study to Test the Design, Functionality, and Ergonomic Features of the AutoinjectorCompletedNCT00643526Early Phase 1
- A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue OutcomesCompletedNCT00642629Phase 2
- Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid ArthritisCompletedNCT00641225Phase 1
- Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT00639834Phase 1
- A Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products in Patients With Rheumatoid ArthritisCompletedNCT00638950Not applicable
- Assessment of the Effectiveness of Low-Level Laser Therapy on the Hands of Patients With Rheumatoid ArthritisCompletedNCT00632710Not applicable
- A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking MethotrexateCompletedNCT00620685Phase 2
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With MethotrexateCompletedNCT00619905Phase 1/2
- Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational StudyCompletedNCT00612885
- GIOP Prevention Among People With Rheumatoid ArthritisCompletedNCT00609830Not applicable